FRI0195 Point-of-care monitoring of anti-infliximab antibodies in patients treated with the reference infliximab or ct-p13 in routine clinical practice
Year: 2017
Type: conference-abstract
Source: Annals of the Rheumatic Diseases
Authors: A Ametzazurra, N Rivera, A Balsa, MP Arreba, E Ruiz, C Plasencia, J Ortiz, D Pascual-Salcedo, MC Muñoz, C De Aysa, MJ Allande, N Torres, AM Hernández, X Recalde, A Martínez, D Nagore
Institutions: Hospital de Basurto, Hospital Universitario La Paz
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
Funder: UCB Pharma
OpenAlex ID: W2741665633
